首页> 外文OA文献 >Comparing Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization Methods to Determine the HER2/neu Status in Primary Breast Carcinoma using Tissue Microarray

【2h】

Comparing Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization Methods to Determine the HER2/neu Status in Primary Breast Carcinoma using Tissue Microarray

机译：将荧光与原位杂交方法的原位杂交方法进行比较，使用组织微阵列测定原发性乳腺癌中的HER2 / Neu状态

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kyeongmee Park; Jungyeon Kim; Sungjig Lim; Sehwan Han; Jung Young Lee;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparing Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization Methods to Determine the HER2|[sol]|neu Status in Primary Breast Carcinoma using Tissue Microarray [J] . Kyeongmee Park, Jungyeon Kim, Sungjig Lim, Modern Pathology . 2003,第9期

机译：比较荧光原位杂交和发色原位杂交方法确定使用组织芯片的原发性乳腺癌中HER2 | [sol] | neu的状态
2. HER2 Positivity in Breast Carcinoma: A Comparison of Chromogenic In Situ Hybridization With Fluorescence In Situ Hybridization in Tissue Microarrays, With Targeted Evaluation of Intratumoral Heterogeneity by In Situ Hybridization. [J] . Loring P, Cummins R, Ogrady A, Applied immunohistochemistry and molecular morphology: AIMM . 2005,第2期

机译：HER2阳性在乳腺癌中：发色原位杂交与荧光原位杂交在组织芯片中的比较，通过原位杂交有针对性地评估肿瘤内异质性。
3. 733 HER2 status in breast carcinomas: comparison between silver in situ hybridization, chromogenic in situ hybridization and fluorescence in situ hybridization [J] . S.A.Md Ali, H.M.Nurhayati, M.A.Munirah, European Journal of Cancer Supplements . 2010,第5期

机译：733 HER2在乳腺癌中的状态：银原位杂交，显色原位杂交和荧光原位杂交的比较
4. Automated cell segmentation and spot detection in fluorescence in situ hybridization staining to assess HER2 status in breast cancer [C] . Şükrü Burak Çetin, Fariba D. Khameneh, Ercan Alp Serteli, Signal Processing and Communications Applications Conference . 2018

机译：荧光原位杂交染色中的自动细胞分割和斑点检测，以评估乳腺癌中HER2的状态
5. Study of miR-21 and miR-221 Expression in Breast Cancer FFPE Tissue Sections by Real Time PCR and Chromogenic in situ Hybridization. [D] . Hug, Kelly A. 2013

机译：实时荧光定量PCR和发色原位杂交研究乳腺癌FFPE组织切片中miR-21和miR-221的表达。
6. Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization [O] . Jens Mollerup, Ulla Henriksen, Sven Müller, 2012

机译：双色发色原位杂交技术测定乳腺癌中HER2的状态：与当前荧光原位杂交技术的大型对比研究
7. Determination of HER2/neu Status: A Pilot Study Comparing HER2/neu Dual In Situ Hybridization DNA Probe Cocktail Assay Performed on Cell Blocks to Immunohistochemisty and Fluorescence In Situ Hybridization Performed on Histologic Specimens [O] . Adria K. Hartman, Blythe K. Gorman, Subhendu Chakraborty, 2014

机译：HER2 / NEU状态的测定：一种试验研究比较HER2 / NEU双向原位杂交DNA探测鸡尾酒测定对细胞嵌段对免疫组化和荧光的原位杂交，对组织学标本进行了杂交

Comparing Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization Methods to Determine the HER2/neu Status in Primary Breast Carcinoma using Tissue Microarray

著录项

引文网络

相似文献

相关主题

期刊订阅